Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context.
Cameroon
Cervical cancer screening
Human immunodeficiency virus (HIV)
Low-income
Social determinants
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
18 02 2021
18 02 2021
Historique:
received:
31
12
2019
accepted:
04
02
2021
entrez:
19
2
2021
pubmed:
20
2
2021
medline:
1
6
2021
Statut:
epublish
Résumé
Cervical cancer is a leading cause of death among Cameroon women. The burden of cervical cancer is in part traceable to the inadequate understanding of socio-contextual determinants of access to screening and prevention opportunities. We explored multilevel individual, community and structural factors that facilitate or inhibit cervical cancer prevention in women at risk in a low-income, high HIV prevalence context. We utilized an exploratory qualitative approach to obtain data through focus group discussions and in-depth interviews from May to August, 2018. A two-stage purposive sampling strategy was used to select 80 women and 20 men who participated in 8 focus group discussions and 8 in-depth interviews. The socio-ecological model guided data analyses to identify micro-, meso-, and macro-level determinants of cervical cancer screening. Micro-level factors including lack of awareness and knowledge about cervical cancer, lack of access to information, excessive cost of cervical cancer screening, low risk perceptions, and poor health seeking behaviors were major barriers for women seeking cervical cancer screening. Meso-level factors, such as social networks, socio-cultural norms, perceptions of the role of men and HIV-related stigma when screening is integrated into HIV care, also engender negative attitudes and behaviors. Macro-level barriers to cervical cancer screening included poorly equipped health facilities and a lack of national cancer prevention policies and programs. In the context of the call for elimination of cervical cancer as a public health problem, our findings highlight challenges and opportunities that should be considered when implementing interventions to increase uptake of cervical cancer screening in low-middle income settings.
Sections du résumé
BACKGROUND
Cervical cancer is a leading cause of death among Cameroon women. The burden of cervical cancer is in part traceable to the inadequate understanding of socio-contextual determinants of access to screening and prevention opportunities. We explored multilevel individual, community and structural factors that facilitate or inhibit cervical cancer prevention in women at risk in a low-income, high HIV prevalence context.
METHODS
We utilized an exploratory qualitative approach to obtain data through focus group discussions and in-depth interviews from May to August, 2018. A two-stage purposive sampling strategy was used to select 80 women and 20 men who participated in 8 focus group discussions and 8 in-depth interviews. The socio-ecological model guided data analyses to identify micro-, meso-, and macro-level determinants of cervical cancer screening.
RESULTS
Micro-level factors including lack of awareness and knowledge about cervical cancer, lack of access to information, excessive cost of cervical cancer screening, low risk perceptions, and poor health seeking behaviors were major barriers for women seeking cervical cancer screening. Meso-level factors, such as social networks, socio-cultural norms, perceptions of the role of men and HIV-related stigma when screening is integrated into HIV care, also engender negative attitudes and behaviors. Macro-level barriers to cervical cancer screening included poorly equipped health facilities and a lack of national cancer prevention policies and programs.
CONCLUSION
In the context of the call for elimination of cervical cancer as a public health problem, our findings highlight challenges and opportunities that should be considered when implementing interventions to increase uptake of cervical cancer screening in low-middle income settings.
Identifiants
pubmed: 33602194
doi: 10.1186/s12905-021-01211-w
pii: 10.1186/s12905-021-01211-w
pmc: PMC7890622
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
74Subventions
Organisme : National Institutes of Health, National Cancer Institute
ID : 3P30CA013330-43S1A
Organisme : National Institutes for Allergy and Infectious Diseases
ID : 5U01AI096299-04
Références
BMC Cancer. 2018 Jul 18;18(1):745
pubmed: 30021564
PLoS One. 2019 Jan 18;14(1):e0211099
pubmed: 30657797
BMC Public Health. 2016 Feb 24;16:181
pubmed: 26911388
Indian J Cancer. 2018 Oct-Dec;55(4):318-326
pubmed: 30829264
Ghana Med J. 2012 Sep;46(3):147-51
pubmed: 23661828
Vaccines (Basel). 2018 Sep 08;6(3):
pubmed: 30205561
Pan Afr Med J. 2019 May 21;33:38
pubmed: 31384353
Asian Pac J Cancer Prev. 2018 Feb 26;19(2):319-324
pubmed: 29479954
Bull World Health Organ. 2008 Aug;86(8):D-E
pubmed: 18797604
BMC Womens Health. 2017 Aug 2;17(1):58
pubmed: 28768506
Front Oncol. 2016 Jun 28;6:160
pubmed: 27446806
Eur J Cancer Care (Engl). 2017 Nov;26(6):
pubmed: 28004448
PLoS One. 2017 Sep 5;12(9):e0183924
pubmed: 28873092
COPD. 2015;12(6):690-702
pubmed: 26263036
BMC Med. 2019 Feb 15;17(1):13
pubmed: 30764817
Salud Publica Mex. 2003;45 Suppl 3:S408-16
pubmed: 14746034
PLoS One. 2017 Jul 21;12(7):e0181156
pubmed: 28732037
BMC Cancer. 2015 Nov 16;15:907
pubmed: 26573809
Int J Womens Health. 2019 Apr 01;11:229-239
pubmed: 31015770
Cancer Med. 2018 Mar;7(3):903-912
pubmed: 29441700
BMC Womens Health. 2018 Sep 24;18(1):155
pubmed: 30249228
Gynecol Oncol Rep. 2020 Jun 22;33:100605
pubmed: 32637528
Pan Afr Med J. 2019 Jun 12;33:106
pubmed: 31489084
BMC Womens Health. 2014 Nov 22;14:138
pubmed: 25416335
Glob Health Action. 2019;12(1):1587894
pubmed: 30938248
BMC Med. 2019 Feb 15;17(1):31
pubmed: 30764826
J Cancer Surviv. 2016 Apr;10(2):291-301
pubmed: 26202538
Glob Health Sci Pract. 2018 Oct 4;6(3):425-438
pubmed: 30143561
Pers Soc Psychol Bull. 2018 Apr;44(4):451-474
pubmed: 29290150